Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study

被引：1

作者：

Naito, Yoichi ^{[1
]}

Doi, Toshihiko ^{[1
]}

Takahashi, Tsuyoshi ^{[2
]}

Kudo, Toshihiro ^{[2
]}

Boku, Narikazu ^{[3
]}

Honma, Yoshitaka ^{[3
]}

Komatsu, Yoshito ^{[4
]}

Nakatsumi, Hiroshi ^{[4
]}

Matsumoto, Koji ^{[5
]}

Onoe, Takuma ^{[5
]}

Oki, Eiji ^{[6
]}

Tsuda, Yasuo ^{[6
]}

Nakamoto, Masako ^{[1
]}

Fukutani, Miki ^{[1
]}

Nomura, Shogo ^{[1
]}

Sato, Akihiro ^{[1
]}

Nishida, Toshirou ^{[3
]}

机构：

[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[2] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan

[3] Natl Canc Ctr, Tokyo, Japan

[4] Hokkaido Univ Hosp, Ctr Canc, Sapporo, Hokkaido, Japan

[5] Hyogo Canc Ctr, Akashi, Hyogo, Japan

[6] Kyushu Univ, Fukuoka, Fukuoka, Japan

来源：

关键词：

D O I：

10.1093/annonc/mdz339.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O2 - 5 - 3

引用

页码：88 / 88

页数：1